Should we wait for the final wound culture before consulting infectious disease in a patient with a leg wound showing a rare growth of Staphylococcus aureus?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Do Not Wait for Final Culture - Consult Infectious Disease Now

You should consult infectious disease immediately upon detection of Staphylococcus aureus in a leg wound culture, even with rare growth, rather than waiting for final culture results. The presence of S. aureus in a wound culture is always clinically significant and warrants early specialist involvement to optimize outcomes and reduce mortality.

Why Early ID Consultation Matters

The evidence strongly supports early infectious disease consultation for S. aureus infections:

  • Mortality reduction: ID consultation for S. aureus infections reduces 30-day mortality by nearly half (12.39% vs 26.07%, RR 0.53) 1
  • Improved management: ID involvement increases appropriate antibiotic selection (RR 1.14), ensures adequate treatment duration (RR 1.85), and increases performance of essential follow-up blood cultures (RR 1.35) and echocardiography (RR 1.98) 1
  • Guideline recommendation: Diabetic foot infection guidelines explicitly state that the multidisciplinary team "should preferably include, or have ready access to, an infectious diseases specialist" 2

Clinical Reasoning for Immediate Consultation

Even "rare growth" of S. aureus requires attention because:

  1. S. aureus is never a contaminant in wound cultures - its presence indicates true infection requiring targeted therapy 3

  2. Risk of complications is substantial - S. aureus causes metastatic infection in >33% of bacteremia cases, including endocarditis (12%), septic arthritis (7%), and osteomyelitis (4%) 3

  3. MRSA prevalence requires early consideration - You need to determine if empiric MRSA coverage is warranted based on patient risk factors (prior MRSA history, recent antibiotics, local prevalence) while awaiting susceptibilities 4

  4. Source control decisions are time-sensitive - ID specialists help determine if surgical debridement, abscess drainage, or other interventions are needed 2

What to Do While Awaiting ID Consultation

Start empiric antibiotics immediately - do not wait for final susceptibilities:

  • For mild-moderate infections without recent antibiotic exposure: Coverage targeting gram-positive cocci (e.g., cephalexin, cefazolin) may suffice 4
  • For moderate-severe infections or recent antibiotic use: Include empiric MRSA coverage (vancomycin, daptomycin, or linezolid) 5
  • Consider MRSA coverage if: prior MRSA history, local MRSA prevalence >30%, or severe infection 4

Obtain proper wound care:

  • Debride necrotic tissue
  • Implement pressure off-loading for lower extremity wounds
  • Ensure adequate wound cleansing 2

Arrange follow-up cultures if not already done - ensure the specimen was obtained properly (tissue biopsy or curettage after debridement, not superficial swab) 4

Common Pitfalls to Avoid

  • Don't dismiss "rare growth" - any S. aureus isolation is clinically relevant and requires treatment 3
  • Don't wait for "final" results - preliminary culture showing S. aureus is sufficient to trigger consultation 1
  • Don't assume antibiotics alone are sufficient - wound care and potential surgical intervention are equally critical 2
  • Don't forget to assess for deeper infection - consider imaging for osteomyelitis if bone is exposed or probed, or if infection is chronic 4

The 50% mortality reduction associated with ID consultation for S. aureus infections 1 makes early involvement a critical intervention that directly impacts patient survival and limb salvage.

Related Questions

What is the recommended treatment for nasal eradication of Staphylococcus aureus colonization?
What is the appropriate management of a local infection of a left‑arm peripherally inserted central catheter (PICC) line in a patient who had a Staphylococcus aureus infection of the contralateral arm PICC three months ago, with no laboratory evidence of sepsis?
In a 77‑year‑old woman with prior Staphylococcus epidermidis bacteremia treated two months ago who now has four months of intermittent sweating and chills, what diagnostic tests should be performed to assess for persistent infection or other causes?
Should a patient with bacteremia be isolated?
What is the recommended flucloxacillin dosing for methicillin‑susceptible Staphylococcus aureus (MSSA) bacteremia?
What is the appropriate dosing and monitoring for escitalopram (Lexapro) in a patient with renal failure?
How should I diagnose and manage a 26-year-old male call‑center worker with a 20‑day history of daily frontal‑parietal migraine‑type headache (pain 7/10), one episode of food‑related vomiting, three episodes of watery diarrhea, tinnitus, worsening after discontinuing glasses, aggravated by bright light and loud noises, and partial relief with acetaminophen, with no red‑flag symptoms?
In a morbidly obese patient, is it appropriate to start aripiprazole (Abilify) at 5 mg?
What are the patient instructions for using ketoconazole 2% shampoo for scalp fungal conditions such as dandruff or seborrheic dermatitis?
Are there any drug interactions between hyoscyamine and potassium chloride?
How often is it recommended to change a silicone-coated latex chronic indwelling Foley catheter (Amsino brand)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.